Paperpal Prime Logo

Journal of Addiction Medicine : Impact Factor & More

eISSN: 1935-3227pISSN: 1932-0620

Key Metrics

CiteScore
4.7
Eigenfactor
0.005 - 0.01
H-Index
53
Impact Factor
5 - 10
SJR
Q1Pharmacology (medical)
SNIP
1.26
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Addiction Medicine

Journal of Addiction Medicine Journal Specifications

Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2007
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Addiction Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Addiction Medicine

Substance Use Among US Adults at Midlife: Risk Factors and Protective Factors Among National and Milwaukee Black American Samples.
  • 29 Jun 2026
  • Journal of addiction medicine
When "Kava" Isn't Kava: Opioid-like Withdrawal Responsive to Buprenorphine: A Case Study.
  • 29 Jun 2026
  • Journal of addiction medicine
Medicaid Prior Authorization and Discontinuation of Buprenorphine.
  • 25 Jun 2026
  • Journal of addiction medicine
Implementation of Dyadic Care to Support Clinical, Administrative, and Service Wraparound Needs for the Opioid-Exposed Mother and Infant.
  • 25 Jun 2026
  • Journal of addiction medicine
Trends in Public Opinion About US Illicit Drug Policy: Results From the 2000 to 2025 Gallup Survey.
  • 25 Jun 2026
  • Journal of addiction medicine
ASAM Consensus Standards for Substance Use Disorder Care Capabilities in Hospitals and Emergency Departments.
  • 19 Jun 2026
  • Journal of addiction medicine
Substance Use Among US Adults at Midlife: Risk Factors and Protective Factors Among National and Milwaukee Black American Samples.
  • 29 Jun 2026
  • Journal of addiction medicine
When "Kava" Isn't Kava: Opioid-like Withdrawal Responsive to Buprenorphine: A Case Study.
  • 29 Jun 2026
  • Journal of addiction medicine
Medicaid Prior Authorization and Discontinuation of Buprenorphine.
  • 25 Jun 2026
  • Journal of addiction medicine
Implementation of Dyadic Care to Support Clinical, Administrative, and Service Wraparound Needs for the Opioid-Exposed Mother and Infant.
  • 25 Jun 2026
  • Journal of addiction medicine
Trends in Public Opinion About US Illicit Drug Policy: Results From the 2000 to 2025 Gallup Survey.
  • 25 Jun 2026
  • Journal of addiction medicine
ASAM Consensus Standards for Substance Use Disorder Care Capabilities in Hospitals and Emergency Departments.
  • 19 Jun 2026
  • Journal of addiction medicine

FAQs on Journal of Addiction Medicine